Initial Hydration Management in Septic Shock
Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours of recognizing septic shock, using balanced crystalloids (lactated Ringer's or Plasma-Lyte) as the preferred fluid type. 1, 2
Immediate Fluid Resuscitation (First 3 Hours)
- Give a minimum of 30 mL/kg of crystalloid solution within 3 hours of identifying sepsis-induced hypoperfusion or septic shock 3, 1
- This is a strong recommendation from the Surviving Sepsis Campaign based on moderate quality evidence, though the evidence base is acknowledged to be limited 1, 4
- Some patients will require more rapid administration and greater volumes beyond this initial bolus 3, 1
- Septic shock is a medical emergency requiring immediate treatment initiation 3
Fluid Type Selection
Crystalloids are the definitive first-choice fluid:
- Use crystalloids as the primary resuscitation fluid (strong recommendation, moderate to high quality evidence) 3, 1, 5
- Prefer balanced crystalloids (lactated Ringer's or Plasma-Lyte) over normal saline to reduce the risk of hyperchloremic metabolic acidosis and potential acute kidney injury 2, 5
- The American College of Critical Care Medicine specifically recommends balanced crystalloids when available 2
Albumin may be added when large volumes are needed:
- Consider albumin supplementation when patients require substantial amounts of crystalloids for ongoing resuscitation 3, 1, 6
- This is a weak recommendation with low quality evidence 3
Hydroxyethyl starches must be completely avoided:
- Do NOT use hydroxyethyl starch solutions due to increased mortality, acute kidney injury, and need for renal replacement therapy (strong recommendation, high quality evidence) 3, 1, 2, 5, 6
Fluid Administration Technique
Use a fluid challenge approach with continuous reassessment:
- Continue administering fluid boluses as long as hemodynamic parameters continue to improve 3, 1, 2
- Stop fluid administration when tissue perfusion stabilizes, no further improvement occurs, or signs of fluid overload develop 2
- Reassess frequently using clinical examination: heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, urine output, mental status, and peripheral perfusion 3, 1
Prefer dynamic over static measures for fluid responsiveness:
- Use dynamic variables (pulse pressure variation, stroke volume variation) rather than static measures (central venous pressure) to predict fluid responsiveness when available 3, 2
- Central venous pressure has poor predictive ability and should not be relied upon solely 2
Vasopressor Initiation
Start vasopressors early if hypotension persists despite adequate fluid resuscitation:
- Initiate norepinephrine as the first-choice vasopressor if hypotension continues after initial fluid resuscitation 1, 2, 7
- Target a mean arterial pressure (MAP) of 65 mmHg (strong recommendation, moderate quality evidence) 3, 1, 2
- Early vasopressor use (within the first hour) may reduce morbidity and mortality compared to prolonged fluid-only resuscitation 8
- The rationale is that vasopressors may be more appropriate than excessive fluid administration, which can lead to fluid overload complications 8, 9
Critical Pitfalls to Avoid
- Do not delay initial resuscitation due to concerns about fluid overload—delayed resuscitation increases mortality 2
- Do not continue aggressive fluid administration beyond the point of hemodynamic improvement, as large positive fluid balance is associated with worse outcomes 4, 9
- Do not use normal saline exclusively when balanced crystalloids are available, particularly in patients with or at risk for acute kidney injury 2, 5
- Do not rely on CVP alone to guide fluid therapy 2
Ongoing Management Beyond Initial Resuscitation
- Following the initial 30 mL/kg bolus, guide additional fluid administration by frequent reassessment of hemodynamic status 3, 1
- Consider the four phases of fluid therapy: resuscitation, optimization, stabilization, and evacuation (de-resuscitation) 9
- Monitor for lactate normalization as a marker of adequate tissue perfusion 3